Herbalife LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Frank Lamberti, Chief Commercial Officer of Herbalife Ltd., reported a transaction in 1,710 shares of common stock on August 4, 2026.
NYSE
Herbalife Ltd. Director Sophie L'Helias purchased 1,200 shares of common stock at a price of $11.31 per share.
NYSE
Herbalife Chief Operating Officer Troy Hicks reported the exercise of stock appreciation rights and subsequent sale of common shares.
NYSE
Chief Commercial Officer Frank Lamberti liquidated nearly 80% of his direct holdings in Herbalife Ltd. over a two-day period in May 2026.
NYSE
Herbalife Ltd. director Lynda Cloud has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Herbalife Ltd. director Maria Otero received a grant of 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Director Richard H. Carmona has been granted 11,879 restricted stock units in Herbalife Ltd., increasing his total beneficial ownership to 83,645 shares.
NYSE
Herbalife Ltd. director Michael J. Levitt has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Director Juan Miguel Mendoza has been granted 11,879 restricted stock units as part of Herbalife Ltd.'s director compensation program.
NYSE
Herbalife Ltd. director Des Walsh has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Herbalife Ltd. director Rodica Macadrai has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Herbalife Ltd. director Donal L. Mulligan has been granted 11,879 restricted stock units as part of the company's long-term incentive compensation strategy.
NYSE
Herbalife Ltd. director Sophie L'Helias has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Herbalife Ltd. director Perkins Miller received a grant of 13,626 restricted stock units as part of the company's 2023 Stock Incentive Plan.
NYSE
Herbalife Ltd. President Robert Levy surrendered 4,904 shares to cover tax liabilities following the vesting of restricted stock units.
NYSE
CEO Stephan Gratziani disposed of 7,873 shares to cover tax liabilities following the vesting of restricted stock units.
NYSE
Herbalife Ltd. Chief Operating Officer Troy Hicks disposed of 6,214 shares to satisfy tax withholding obligations following the vesting of restricted stock units.
NYSE
Herbalife Ltd. Chief Legal Officer Henry C. Wang disposed of 10,562 shares to cover tax obligations following the vesting of restricted stock units.
NYSE
SVP and Chief Accounting Officer Jehangir D. Irani disposed of 9,053 shares to cover tax liabilities following the vesting of restricted stock units.
NYSE
Herbalife's Chief Commercial Officer, Frank Lamberti, disposed of 8,224 shares to cover tax liabilities following the vesting of restricted stock units.
NYSE
Herbalife's Chief Financial Officer, John DeSimone, filed an amended Form 4 to correct the exercise price of 45,195 Stock Appreciation Rights.
NYSE
Herbalife's Chief Commercial Officer, Frank Lamberti, filed an amended Form 4 to correct the exercise price of his Stock Appreciation Rights from $10.51 to $19.26.
NYSE
Herbalife's Executive Chairman, Michael Johnson, filed an amended Form 4 to correct the exercise price of recently granted Stock Appreciation Rights.
NYSE
Herbalife Ltd. filed an amendment to correct the exercise price of Stock Appreciation Rights granted to its Chief Legal Officer, Henry C. Wang, from $10.51 to $19.26.
NYSE
Herbalife Ltd. filed an amendment to correct the exercise price of President Robert Levy's Stock Appreciation Rights from $10.51 to $19.26.
NYSE
Herbalife's Chief Operating Officer, Troy Hicks, filed an amended Form 4 to correct the exercise price of 33,301 Stock Appreciation Rights to $19.26.
NYSE
Herbalife Ltd. CEO Stephan Paulo Gratziani's Stock Appreciation Rights exercise price has been corrected to $19.26 from $10.51 in an amended SEC filing.
NYSE
Herbalife Ltd. President Robert Levy received a grant of 33,301 Stock Appreciation Rights with a $10.51 exercise price, vesting over three years.
NYSE
Herbalife's Chief Commercial Officer, Frank Lamberti, was granted 40,437 Stock Appreciation Rights with a $10.51 exercise price, vesting over three years.
NYSE
Herbalife Ltd. granted Executive Chairman Michael Johnson 72,689 restricted stock units and 399,619 stock appreciation rights, vesting over two years.